LEADING MED

REVISCON RE-CROSS

LEADING MED

REVISCON RE-CROSS
Medical Device

LEADING MED

REVISCON
Medical Device

Viscoelastic solution of lightly cross-linked hyaluronic acid for single injection, ensuring longer duration in intra-articular use.
Composed of 4.0 ml of viscoelastic solution in a 5.0 ml disposable syringe.
Sterile, pyrogen-free, transparent, non-inflammatory, lightly cross-linked hyaluronic acid for structured intra-articular injection, dissolved in a buffered physiological saline solution.

The hyaluronic acid is obtained through bacterial fermentation and cross-linked with a very low amount of cross-linking agent. Thanks to the specific purification process during production, a highly purified product is obtained, ensuring patient safety.
Contains lightly cross-linked hyaluronic acid, sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, and water for injectable preparations.

Viscoelastic solution of lightly cross-linked hyaluronic acid for single injection, ensuring longer duration in intra-articular use.
Composed of 4.0 ml of viscoelastic solution in a 5.0 ml disposable syringe.
Sterile, pyrogen-free, transparent, non-inflammatory, lightly cross-linked hyaluronic acid for structured intra-articular injection, dissolved in a buffered physiological saline solution.
The hyaluronic acid is obtained through bacterial fermentation and cross-linked with a very low amount of cross-linking agent. Thanks to the specific purification process during production, a highly purified product is obtained, ensuring patient safety.
Contains lightly cross-linked hyaluronic acid, sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, and water for injectable preparations.

REQUEST INFORMATION

REQUEST INFORMATION